Skip to main content
. 2022 Dec 31;19(4):935–945. doi: 10.14245/ns.2244628.314

Fig. 2.

Fig. 2.

Schematic illustration of iPSC-NPC transplantation therapy in the clinical trial. iPSC, induced pluripotent stem cell; NPC, neural precursor cell; HLA, human leukocyte antigen; SCI, spinal cord injury; CiRA, Center for iPS Cell Research and Application.